Richard E. Pratley, MD, previews “Effect of Oral Semaglutide With or Without Background SGLT2i in Patients with T2D: Subgroup Analysis of PIONEER 4,” which will begin at 10:00 a.m. CT Saturday, June 13.
News Updates from the 83rd Scientific Sessions
Richard E. Pratley, MD, previews “Effect of Oral Semaglutide With or Without Background SGLT2i in Patients with T2D: Subgroup Analysis of PIONEER 4,” which will begin at 10:00 a.m. CT Saturday, June 13.